SG42947A1 - Stable extended release oral dosage composition - Google Patents

Stable extended release oral dosage composition

Info

Publication number: SG42947A1
Authority: SG; Singapore
Prior art keywords: oral dosage; extended release; release oral; dosage composition; stable extended
Prior art date: 1992-10-23

Application number

SG1996001282A

Other languages

English (en)

Inventor

Henry K Kwan

Stephen M Liebowitz

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-10-23

Filing date

1993-10-21

Publication date

1997-10-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25510010&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG42947(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1993-10-21 Application filed by Schering Corp filed Critical Schering Corp

1997-10-17 Publication of SG42947A1 publication Critical patent/SG42947A1/en

Links

238000013265 extended release Methods 0.000 title abstract 2
CAVQBDOACNULDN-NRCOEFLKSA-N (1s,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric acid Chemical compound OS(O)(=O)=O.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1.CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 CAVQBDOACNULDN-NRCOEFLKSA-N 0.000 abstract 1
206010028735 Nasal congestion Diseases 0.000 abstract 1
GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
230000001387 anti-histamine Effects 0.000 abstract 1
239000000739 antihistaminic agent Substances 0.000 abstract 1
239000007888 film coating Substances 0.000 abstract 1
238000009501 film coating Methods 0.000 abstract 1
JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 abstract 1
229960003088 loratadine Drugs 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
239000000133 nasal decongestant Substances 0.000 abstract 1
229920000642 polymer Polymers 0.000 abstract 1
229960004159 pseudoephedrine sulfate Drugs 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
230000001624 sedative effect Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Cosmetics (AREA)

SG1996001282A 1992-10-23 1993-10-21 Stable extended release oral dosage composition SG42947A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/965,470 US5314697A (en)	1992-10-23	1992-10-23	Stable extended release oral dosage composition comprising loratadine and pseudoephedrine

Publications (1)

Publication Number	Publication Date
SG42947A1 true SG42947A1 (en)	1997-10-17

Family

ID=25510010

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996001282A SG42947A1 (en)	1992-10-23	1993-10-21	Stable extended release oral dosage composition

Country Status (27)

Country	Link
US (1)	US5314697A (cs)
EP (1)	EP0665744B1 (cs)
JP (1)	JP3580815B2 (cs)
KR (1)	KR100283709B1 (cs)
CN (1)	CN1038474C (cs)
AT (1)	ATE161420T1 (cs)
AU (1)	AU676229B2 (cs)
CA (1)	CA2147606C (cs)
CZ (1)	CZ287687B6 (cs)
DE (1)	DE69316023T2 (cs)
DK (1)	DK0665744T3 (cs)
EE (1)	EE03106B1 (cs)
ES (1)	ES2110633T3 (cs)
FI (1)	FI112916B (cs)
GR (1)	GR3026198T3 (cs)
HU (1)	HU220629B1 (cs)
IL (1)	IL107354A (cs)
MY (1)	MY109090A (cs)
NO (1)	NO308771B1 (cs)
NZ (1)	NZ257447A (cs)
PH (1)	PH29940A (cs)
PL (1)	PL172862B1 (cs)
SG (1)	SG42947A1 (cs)
SK (1)	SK281090B6 (cs)
TW (1)	TW251239B (cs)
WO (1)	WO1994009761A1 (cs)
ZA (1)	ZA937830B (cs)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996010996A1 (en) *	1993-07-21	1996-04-18	The University Of Kentucky Research Foundation	A multicompartment hard capsule with control release properties
US6746691B2 (en)	1993-09-20	2004-06-08	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6676967B1 (en) *	1993-09-20	2004-01-13	Kos Pharmaceuticals, Inc.	Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6818229B1 (en)	1993-09-20	2004-11-16	Kos Pharmaceuticals, Inc.	Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6129930A (en)	1993-09-20	2000-10-10	Bova; David J.	Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6080428A (en)	1993-09-20	2000-06-27	Bova; David J.	Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US7214683B1 (en)	1994-12-30	2007-05-08	Sepracor Inc.	Compositions of descarboethoxyloratadine
US7211582B1 (en)	1994-12-30	2007-05-01	Sepracor Inc.	Methods for treating urticaria using descarboethoxyloratadine
EP0812195B1 (en) *	1995-02-28	2002-10-30	Aventis Pharmaceuticals Inc.	Pharmaceutical composition for piperidinoalkanol compounds
US5807579A (en) *	1995-11-16	1998-09-15	F.H. Faulding & Co. Limited	Pseudoephedrine combination pharmaceutical compositions
EP0811374A1 (en)	1996-05-29	1997-12-10	Pfizer Inc.	Combination dosage form comprising cetirizine and pseudoephedrine
EP0941091A1 (en) *	1996-10-31	1999-09-15	Schering Corporation	Composition, for the treatment of asthma, containing loratadine and a decongestant
TW522014B (en) *	1997-02-07	2003-03-01	Sepracor Inc	Lactose-free, non-hygroscopic and anhydrous pharmaceutical unit dosage form containing descarboethoxyloratadine
BE1011045A3 (fr)	1997-03-14	1999-04-06	Ucb Sa	Compositions pharmaceutiques pour la liberation controlee de substances actives.
NZ501248A (en) *	1997-08-26	2001-06-29	Aventis Pharma Inc	Pharmaceutical composition for combination of piperidinoalkanol-decongestant
AU6018899A (en) *	1998-09-10	2000-04-03	Schering Corporation	Antihistamines for treating non-infective sinusitis or otitis media
US6051585A (en) *	1998-12-07	2000-04-18	Weinstein; Robert E.	Single-dose antihistamine/decongestant formulations for treating rhinitis
US6521254B2 (en)	1998-12-07	2003-02-18	J-Med Pharmaceuticals, Inc.	Single-dose antihistamine/decongestant formulations for treating rhinitis
KR100505899B1 (ko) *	1999-02-23	2005-08-01	주식회사유한양행	로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
ATE253354T1 (de) *	1999-02-23	2003-11-15	Yuhan Corp	Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
US6555139B2 (en)	1999-06-28	2003-04-29	Wockhardt Europe Limited	Preparation of micron-size pharmaceutical particles by microfluidization
US6100274A (en) *	1999-07-07	2000-08-08	Schering Corporation	8-chloro-6,11-dihydro-11- ](4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions
US6267986B1 (en) *	1999-09-24	2001-07-31	Ranbaxy Laboratories Limited	Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
US6114346A (en)	1999-10-22	2000-09-05	Schering Corporation	Treating sleep disorders using desloratadine
WO2001045668A2 (en) *	1999-12-20	2001-06-28	Schering Corporation	Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine
WO2001045676A2 (en) *	1999-12-20	2001-06-28	Schering Corporation	Extended release oral dosage composition
US7147870B2 (en) *	2000-01-13	2006-12-12	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist
US6613357B2 (en) *	2000-01-13	2003-09-02	Osmotica Corp.	Osmotic device containing pseudoephedrine and an H1 antagonist
US7405223B2 (en)	2000-02-03	2008-07-29	Schering Corporation	Treating allergic and inflammatory conditions
JP5592042B2 (ja) *	2000-04-14	2014-09-17	ジェイ−メドファーマシューティカルズ，インコーポレーティッド	鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
US20020094345A1 (en) *	2000-10-06	2002-07-18	Sara Abelaira	Pharmaceutical compositions containing epinastine and pseudoephedrine
AU2002220248A1 (en) *	2000-11-06	2002-05-15	Andrx Pharmaceuticals, Inc.	Once a day antihistamine and decongestant formulation
WO2003000264A1 (en) *	2001-06-20	2003-01-03	Schering Corporation	Antihistamines for the treatment of nasal congestion and nasal obstruction
US6720002B2 (en)	2001-07-20	2004-04-13	R.P. Scherer Technologies, Inc.	Antihistamine formulations for soft capsule dosage forms
US6863901B2 (en)	2001-11-30	2005-03-08	Collegium Pharmaceutical, Inc.	Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en)	2001-12-05	2004-12-07	Collegium Pharmaceutical, Inc.	Compositions containing both sedative and non-sedative antihistamines
AU2002351655A1 (en) *	2002-08-29	2004-03-19	Osmotica Corp.	Device for release of a drug containing oseltamivir and a h1 antagonist
US20040051686A1 (en) *	2002-09-17	2004-03-18	Yuan-Sung Weng	Carry-on device having functions of both digital photographing and timing
US8092831B2 (en) *	2002-11-08	2012-01-10	Andrx Pharmaceuticals, Llc	Antihistamine and decongestant system
US20050013863A1 (en) *	2003-07-18	2005-01-20	Depomed, Inc., A Corporation Of The State Of California	Dual drug dosage forms with improved separation of drugs
US8246986B2 (en)	2003-09-26	2012-08-21	Alza Corporation	Drug coating providing high drug loading
US20050095288A1 (en) *	2003-11-03	2005-05-05	Andrx Labs, Llc	Decongestant and expectorant tablets
EP1700591A4 (en) *	2003-12-01	2011-08-03	Takeda Pharmaceutical	METHOD FOR THE TREATMENT OF A SOLID PHARMACEUTICAL PREPARATION BEFORE PRINTING AND PRESTIGIOUS SOLENOID PREPARATION TREATED BEFORE PRINTING
US20050266032A1 (en) *	2003-12-17	2005-12-01	Sovereign Pharmaceuticals, Ltd.	Dosage form containing multiple drugs
SE0401031D0 (sv)	2004-04-22	2004-04-22	Duocort Ab	A new glucocorticoid replacement therapy
US20060024368A1 (en) *	2004-07-30	2006-02-02	Reza Fassihi	Compressed composite delivery system for release-rate modulation of bioactives
ES2294979T1 (es) *	2005-01-27	2008-04-16	Alembic Limited	Formulacion de levetiracetam de liberacion prolongada.
US20070036859A1 (en) *	2005-08-11	2007-02-15	Perry Ronald L	Sustained release antihistamine and decongestant composition
JP5121824B2 (ja) *	2006-06-01	2013-01-16	メルク・シャープ・アンド・ドーム・コーポレーション	フェニレフリンの徐放のための薬学的組成物
CN101015519B (zh) *	2007-02-27	2012-03-21	重庆医药工业研究院有限责任公司	一种氯雷他定口服复方药物组合物
EP2120945A1 (en) *	2007-02-28	2009-11-25	Collegium Pharmaceutical, Inc.	Antihistamine combination
CA2724533C (en) *	2008-07-24	2014-07-29	Handa Pharmaceuticals, Llc	Stabilized atypical antipsychotic formulation
DK3045043T3 (da)	2009-02-26	2020-08-03	Relmada Therapeutics Inc	Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
CA2690490C (en)	2010-01-19	2012-06-26	Accucaps Industries Limited	Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
CN102160859B (zh) *	2011-02-23	2012-11-07	海南斯达制药有限公司	一种氯雷伪麻复方缓释药物
JP5752578B2 (ja) *	2011-12-09	2015-07-22	ジェイ−メドファーマシューティカルズ，インコーポレーティッド	鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
CN104983708A (zh) *	2015-06-24	2015-10-21	万特制药(海南)有限公司	一种地氯雷他定硫酸伪麻黄碱缓释片及其制备方法
CN108576895B (zh) *	2018-03-06	2021-04-30	特素生物科技（天津）有限公司	缓释营养主食及其制备方法
PY2162539A (es)	2020-07-30	2022-02-15	Faes Farma Sa	Sistema de administración de fármacos descongestivos y bilastina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4282233B1 (en) *	1980-06-19	2000-09-05	Schering Corp	Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4601894A (en) *	1985-03-29	1986-07-22	Schering Corporation	Controlled release dosage form comprising acetaminophen, pseudoephedrine sulfate and dexbrompheniramine maleate
IE60311B1 (en) *	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
CN1053570C (zh) *	1987-10-07	2000-06-21	默尔多药物公司	哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4990535A (en) *	1989-05-03	1991-02-05	Schering Corporation	Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine

1992
- 1992-10-23 US US07/965,470 patent/US5314697A/en not_active Expired - Lifetime
1993
- 1993-10-21 DE DE69316023T patent/DE69316023T2/de not_active Expired - Lifetime
- 1993-10-21 KR KR1019950701529A patent/KR100283709B1/ko not_active Expired - Lifetime
- 1993-10-21 IL IL107354A patent/IL107354A/en not_active IP Right Cessation
- 1993-10-21 ZA ZA937830A patent/ZA937830B/xx unknown
- 1993-10-21 SK SK522-95A patent/SK281090B6/sk not_active IP Right Cessation
- 1993-10-21 MY MYPI93002189A patent/MY109090A/en unknown
- 1993-10-21 AU AU54050/94A patent/AU676229B2/en not_active Expired
- 1993-10-21 AT AT93924327T patent/ATE161420T1/de active
- 1993-10-21 PH PH47120A patent/PH29940A/en unknown
- 1993-10-21 SG SG1996001282A patent/SG42947A1/en unknown
- 1993-10-21 CA CA002147606A patent/CA2147606C/en not_active Expired - Lifetime
- 1993-10-21 HU HU9501143A patent/HU220629B1/hu unknown
- 1993-10-21 PL PL93308491A patent/PL172862B1/pl unknown
- 1993-10-21 WO PCT/US1993/009873 patent/WO1994009761A1/en not_active Ceased
- 1993-10-21 DK DK93924327T patent/DK0665744T3/da active
- 1993-10-21 JP JP51111094A patent/JP3580815B2/ja not_active Expired - Lifetime
- 1993-10-21 NZ NZ257447A patent/NZ257447A/en not_active IP Right Cessation
- 1993-10-21 EP EP93924327A patent/EP0665744B1/en not_active Expired - Lifetime
- 1993-10-21 CZ CZ19951014A patent/CZ287687B6/cs not_active IP Right Cessation
- 1993-10-21 ES ES93924327T patent/ES2110633T3/es not_active Expired - Lifetime
- 1993-10-22 TW TW082108823A patent/TW251239B/zh not_active IP Right Cessation
- 1993-10-22 CN CN93118769A patent/CN1038474C/zh not_active Expired - Lifetime
1994
- 1994-11-21 EE EE9400250A patent/EE03106B1/xx unknown
1995
- 1995-04-21 FI FI951901A patent/FI112916B/fi not_active IP Right Cessation
- 1995-04-21 NO NO19951527A patent/NO308771B1/no not_active IP Right Cessation
1998
- 1998-02-23 GR GR980400376T patent/GR3026198T3/el unknown

Also Published As

Publication number	Publication date
KR100283709B1 (ko)	2001-03-02
PL172862B1 (pl)	1997-12-31
AU676229B2 (en)	1997-03-06
FI951901A0 (fi)	1995-04-21
HK1004327A1 (en)	1998-11-20
HUT71682A (en)	1996-01-29
TW251239B (cs)	1995-07-11
EE03106B1 (et)	1998-08-17
HU220629B1 (hu)	2002-03-28
IL107354A0 (en)	1994-01-25
MY109090A (en)	1996-11-30
HU9501143D0 (en)	1995-06-28
DE69316023T2 (de)	1998-04-23
FI951901L (fi)	1995-04-21
IL107354A (en)	1998-02-08
FI112916B (fi)	2004-02-13
ES2110633T3 (es)	1998-02-16
ZA937830B (en)	1994-04-21
PL308491A1 (en)	1995-08-07
CA2147606C (en)	2000-10-10
NZ257447A (en)	1996-09-25
NO308771B1 (no)	2000-10-30
CA2147606A1 (en)	1994-05-11
JPH08502516A (ja)	1996-03-19
JP3580815B2 (ja)	2004-10-27
EP0665744B1 (en)	1997-12-29
DK0665744T3 (da)	1998-09-07
SK52295A3 (en)	1997-05-07
NO951527D0 (no)	1995-04-21
CN1038474C (zh)	1998-05-27
DE69316023D1 (de)	1998-02-05
AU5405094A (en)	1994-05-24
GR3026198T3 (en)	1998-05-29
EP0665744A1 (en)	1995-08-09
PH29940A (en)	1996-09-16
SK281090B6 (sk)	2000-11-07
CZ101495A3 (en)	1996-02-14
ATE161420T1 (de)	1998-01-15
US5314697A (en)	1994-05-24
NO951527L (no)	1995-06-20
WO1994009761A1 (en)	1994-05-11
CZ287687B6 (en)	2001-01-17
CN1089471A (zh)	1994-07-20
KR950703937A (ko)	1995-11-17

Publication	Publication Date	Title
TW251239B (cs)	1995-07-11
MXPA00013037A (es)	2003-06-19	Composicion estable para dosis oral de liberacion extendida.
US4552899B1 (cs)	1992-10-20
ZA882884B (en)	1988-10-27	Cough/cold mixtures comprising non-sedating antihistamine drugs
ATE145551T1 (de)	1996-12-15	Brausedosisform sowie verfahren zu deren verabreichung
EP0316434A4 (en)	1989-10-16	Cough and cold mixtures comprising antihistamine drugs without sedative effects.
MY126555A (en)	2006-10-31	Oral pharmaceutical extended release dosage form
HUT70438A (en)	1995-10-30	Pharmaceutical retarde composition containing tramadol salt
GEP20033014B (en)	2003-07-25	Enteric Coated Pharmaceutical Composition and Method of Manufacturing
DK0577504T3 (da)	2003-03-17	Niacin-holdige sustained release-tabletter og -kits
MX9706769A (es)	1997-11-29	Formas de dosificacion farmaceutica que comprenden un inhibidor de la bomba de protones y un agente procinetico.
HUT62192A (en)	1993-04-28	Process for producing pharmaceutical compositions comprising tomoxetine and suitable for treating diseases of lower urinary tract
UA19756A1 (uk)	1997-12-25	Спосіб одержаhhя піперазиhілалкіл-3(2h)піридазиhоhів або їх фармацевтичhо прийhятих солей
AU2700488A (en)	1989-06-22	Pharmaceutical compositions containing dyclonine hcl and phenol
AU2908389A (en)	1989-07-19	Device for administering medicaments by atomization in intubated or tracheotomized patients
JPS527567A (en)	1977-01-20	Apparatus for transferring medicines for individual patients
DE69026295D1 (de)	1996-05-09	Pharmazeutische Zusammensetzung gegen durch Vasokonstriktion hervorgerufene Krankheiten